Insurance Tara Bannow STAT Plus: Insurers hint at suing Biden administration over plans for Medicare Advantage audits
Politics Sarah Owermohle Still fuming over the federal Covid response, Republicans redirect the House coronavirus committee
Politics Sarah Owermohle STAT Plus: Rep. Jason Smith and the other Republicans leading health policy in the House
Insurance Tara Bannow STAT Plus: Biden administration takes aim at Medicare Advantage care denials, misleading ads
Politics Nicholas Florko STAT Plus: The FDA has banned certain vapes and medicines. We still bought these 13 products in its backyard
Politics Rachel Cohrs A Democratic Senate improves the outlook for Biden health and science priorities, including key nominees
Health Care Inc. Bob Herman Medicare’s midterm punts, MA marketing schemes, and a closer look at the Abiomed deal
Health Ambar Castillo In Fiona-ravaged Puerto Rico, hospitals were prioritized over health clinics for diesel, exacerbating rural health disparities
Health Tech Mohana Ravindranath STAT Plus: Health plans say texting could help reach underserved patients. But a federal rule is getting in their way
Health Nicholas Florko STAT Plus: The U.S. is terrible at keeping businesses from worsening public health, experts say
Insurance Bob Herman STAT Plus: Errors have plagued insurance directories of doctors. The government wants to clean them up with its own
Exclusive Rachel Cohrs STAT Plus: Medicare lays out the bureaucracy it will need to negotiate drug prices
D.C. Diagnosis Sarah Owermohle Health funding battles, a nutrition policy overhaul, and two CBD developments
Insurance Bob Herman STAT Plus: Health insurers are painting a misleading picture of Medicare Advantage savings, experts say
Exclusive Rachel Cohrs STAT Plus: White House pitches drug pricing reforms as a way to extend cancer patients’ lives
Politics Nicholas Florko STAT Plus: Coors, Mondelez, and other big food companies want to sell CBD-filled food and drinks. The FDA is staunchly opposed
Insurance Bob Herman STAT Plus: Humana appeases Wall Street with big projections of Medicare Advantage growth
A STAT Investigation Nicholas Florko With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem
First Opinion Blair L. Sadler and Alfred M. Sadler, Jr. Organ transplantation is at a crossroads. Major reform is needed
First Opinion Linda Richter THC ingestion by young kids highlights the need to tighten inadequate packaging regulations
Hospitals Tara Bannow STAT Plus: Medicare wants to stop publishing some hospital safety data next year